Literature DB >> 33643319

Case Report: Mastocytosis: The Long Road to Diagnosis.

Tiago Azenha Rama1,2, Diana Martins3, Nuno Gomes4, Jorge Pinheiro3, Ana Nogueira4, Luís Delgado1,2,5, José Luís Plácido1, Alice Coimbra1.   

Abstract

Mastocytosis is a heterogeneous group of disorders characterized by expansion and accumulation of clonal mast cells. Patients mainly present with either cutaneous lesions, anaphylaxis, or both. Its low prevalence and unusual features often hinder its diagnosis for several years. We report the case of an 18-year-old male who was referred to our department with a long-standing history of atypical skin lesions, allergic rhinitis, exercise-induced bronchoconstriction and what was believed to be food-related flushing and anaphylaxis, that was later diagnosed with mastocytosis. This case illustrates the need to consider investigating for mastocytosis when recurrent anaphylaxis is present, especially in the presence of atypical skin lesions, even if normal serum basal tryptase levels and allergic sensitization are present.
Copyright © 2021 Rama, Martins, Gomes, Pinheiro, Nogueira, Delgado, Plácido and Coimbra.

Entities:  

Keywords:  anaphylaxis; diagnostics; flushing; food allergy; mastocytosis

Year:  2021        PMID: 33643319      PMCID: PMC7907169          DOI: 10.3389/fimmu.2021.635909

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  32 in total

1.  Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.

Authors:  Melody C Carter; Jamie A Robyn; Peter B Bressler; John C Walker; Gail G Shapiro; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2007-05-03       Impact factor: 10.793

2.  Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.

Authors:  Tim Wiechers; Anja Rabenhorst; Tina Schick; Liane M Preussner; Anja Förster; Peter Valent; Hans-Peter Horny; Karl Sotlar; Karin Hartmann
Journal:  J Allergy Clin Immunol       Date:  2015-07-04       Impact factor: 10.793

Review 3.  Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Authors:  Karin Hartmann; Luis Escribano; Clive Grattan; Knut Brockow; Melody C Carter; Ivan Alvarez-Twose; Almudena Matito; Sigurd Broesby-Olsen; Frank Siebenhaar; Magdalena Lange; Marek Niedoszytko; Mariana Castells; Joanna N G Oude Elberink; Patrizia Bonadonna; Roberta Zanotti; Jason L Hornick; Antonio Torrelo; Jürgen Grabbe; Anja Rabenhorst; Boguslaw Nedoszytko; Joseph H Butterfield; Jason Gotlib; Andreas Reiter; Deepti Radia; Olivier Hermine; Karl Sotlar; Tracy I George; Thomas K Kristensen; Hanneke C Kluin-Nelemans; Selim Yavuz; Hans Hägglund; Wolfgang R Sperr; Lawrence B Schwartz; Massimo Triggiani; Marcus Maurer; Gunnar Nilsson; Hans-Peter Horny; Michel Arock; Alberto Orfao; Dean D Metcalfe; Cem Akin; Peter Valent
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

4.  Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.

Authors:  Fatma Jendoubi; Nicolas Gaudenzio; Adeline Gallini; Mathilde Negretto; Carle Paul; Cristina Bulai Livideanu
Journal:  Clin Exp Allergy       Date:  2020-03-25       Impact factor: 5.018

5.  Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.

Authors:  Emilie Perino; Nathalie Freymond; Gilles Devouassoux; Jean-François Nicolas; Frédéric Berard
Journal:  Ann Allergy Asthma Immunol       Date:  2018-02-23       Impact factor: 6.347

Review 6.  Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms.

Authors:  Peter Valent; Karl Sotlar; Hans-Peter Horny
Journal:  Leuk Lymphoma       Date:  2011-01-24

7.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.

Authors:  K Brockow; C Jofer; H Behrendt; J Ring
Journal:  Allergy       Date:  2008-02       Impact factor: 13.146

8.  Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Authors:  P Valent; L Escribano; S Broesby-Olsen; K Hartmann; C Grattan; K Brockow; M Niedoszytko; B Nedoszytko; J N G Oude Elberink; T Kristensen; J H Butterfield; M Triggiani; I Alvarez-Twose; A Reiter; W R Sperr; K Sotlar; S Yavuz; H C Kluin-Nelemans; O Hermine; D Radia; J J van Doormaal; J Gotlib; A Orfao; F Siebenhaar; L B Schwartz; M Castells; M Maurer; H-P Horny; C Akin; D D Metcalfe; M Arock
Journal:  Allergy       Date:  2014-05-19       Impact factor: 13.146

9.  Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.

Authors:  Kari C Nadeau; Lynda C Schneider; Lisa Hoyte; Irene Borras; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

Review 10.  KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Authors:  M Arock; K Sotlar; C Akin; S Broesby-Olsen; G Hoermann; L Escribano; T K Kristensen; H C Kluin-Nelemans; O Hermine; P Dubreuil; W R Sperr; K Hartmann; J Gotlib; N C P Cross; T Haferlach; A Garcia-Montero; A Orfao; J Schwaab; M Triggiani; H-P Horny; D D Metcalfe; A Reiter; P Valent
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.